Daiichi Sankyo is dedicated not only to developing cutting-edge treatments but also to ensuring these medications reach the patients who need them most. Our commitment extends to providing comprehensive support services, making access to our therapies as seamless as possible.
Daiichi Sankyo Access Central serves as a central hub for information and assistance, specifically designed to help patients navigate the process of accessing our products. For eligible patients who are uninsured or underinsured, the program offers the vital option of receiving medication at no cost. We understand that each patient’s journey is unique, and Access Central Coordinators are readily available to provide personalized support and guidance.
Connect with a Daiichi Sankyo Access Central Coordinator today to explore available support options.
Visit www.DSIAccessCentral.com for comprehensive details.
The Access Central website provides extensive resources regarding medication coverage, access support, financial assistance programs, and other valuable patient resources.
Daiichi Sankyo’s portfolio of covered products includes:
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki): For complete prescribing information, including boxed warnings and medication guide, please refer to the full prescribing information and medication guide.
-
INJECTAFER® (ferric carboxymaltose injection): Access the full prescribing information for detailed product information.
-
TURALIO® (pexidartinib): For complete prescribing information, including boxed warning regarding liver toxicity and medication guide, please see the full prescribing information and medication guide.
Partnership for Prescription Assistance (PPA)
Daiichi Sankyo, Inc. proudly participates in the Pharmaceutical Research and Manufacturers of America’s Partnership for Prescription Assistance (PPA). PPA is a nationwide collaboration bringing together pharmaceutical companies, healthcare professionals, patient advocates, and community groups. This program is designed to assist patients in identifying potential prescription assistance programs for which they may be eligible. The PPA also helps with eligibility assessment and provides necessary enrollment forms. For further information, please visit www.pparx.org.
Continue to PPA Website Return to Daiichi Sankyo Website
Please note: Clicking “Continue” will redirect you to an external website managed by a third party. Daiichi Sankyo, Inc. is not responsible for the content, accuracy, or privacy practices of external websites. We encourage you to review the privacy policy of any website you visit.
